[{"id":"d3344f00-f5ec-40a4-b3ab-6fb2cfceee7b","acronym":"","url":"https://clinicaltrials.gov/study/NCT05013372","created_at":"2021-08-19T14:52:58.496Z","updated_at":"2024-07-02T16:36:06.249Z","phase":"Phase 1","brief_title":"CD147-CAR T Cells for Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma","source_id_and_acronym":"NCT05013372","lead_sponsor":"Peking University People's Hospital","biomarkers":" ALK • BSG","pipe":" | ","alterations":" ALK positive • ALK negative","tags":["ALK • BSG"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ALK positive • ALK negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD147-CAR T cells"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 12","initiation":"Initiation: 01/01/2023","start_date":" 01/01/2023","primary_txt":" Primary completion: 01/01/2024","primary_completion_date":" 01/01/2024","study_txt":" Completion: 01/01/2025","study_completion_date":" 01/01/2025","last_update_posted":"2022-08-02"}]